Design of DNA Minor Groove Binding Diamidines That Recognize GC Base Pair Sequences: A Dimeric-Hinge Interaction Motif
- 13 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 129 (44), 13732-13743
- https://doi.org/10.1021/ja074560a
Abstract
The classical model of DNA minor groove binding compounds is that they should have a crescent shape that closely fits the helical twist of the groove. Several compounds with relatively linear shape and large dihedral twist, however, have been found recently to bind strongly to the minor groove. These observations raise the question of how far the curvature requirement could be relaxed. As an initial step in experimental analysis of this question, a linear triphenyl diamidine, DB1111, and a series of nitrogen tricyclic analogues were prepared. The goal with the heterocycles is to design GC binding selectivity into heterocyclic compounds that can get into cells and exert biological effects. The compounds have a zero radius of curvature from amidine carbon to amidine carbon but a significant dihedral twist across the tricyclic and amidine-ring junctions. They would not be expected to bind well to the DNA minor groove by shape-matching criteria. Detailed DNase I footprinting studies of the sequence specificity of this set of diamidines indicated that a pyrimidine heterocyclic derivative, DB1242, binds specifically to a GC-rich sequence, −GCTCG−. It binds to the GC sequence more strongly than to the usual AT recognition sequences for curved minor groove agents. Other similar derivatives did not exhibit the GC specificity. Biosensor-surface plasmon resonance and isothermal titration calorimetry experiments indicate that DB1242 binds to the GC sequence as a highly cooperative stacked dimer. Circular dichroism results indicate that the compound binds in the minor groove. Molecular modeling studies support a minor groove complex and provide an inter-compound and compound−DNA hydrogen-bonding rational for the unusual GC binding specificity and the requirement for a pyrimidine heterocycle. This compound represents a new direction in the development of DNA sequence-specific agents, and it is the first non-polyamide, synthetic compound to specifically recognize a DNA sequence with a majority of GC base pairs.This publication has 53 references indexed in Scilit:
- Diphenyl Furans and Aza Analogs: Effects of Structural Modification on In Vitro Activity, DNA Binding, and Accumulation and Distribution in TrypanosomesAntimicrobial Agents and Chemotherapy, 2007
- Predicting protein druggabilityDrug Discovery Today, 2005
- The druggable genome: an updateDrug Discovery Today, 2005
- Transmission coefficient calculation for proton transfer in triosephosphate isomerase based on the reaction path potential methodThe Journal of Chemical Physics, 2004
- Flexible Structure of DNA: Ion Dependence of Minor-Groove Structure and DynamicsJournal of the American Chemical Society, 2000
- A thermodynamic and structural analysis of DNA minor-groove complex formationJournal of Molecular Biology, 2000
- Development and Validation of a Homology Model of Human Cathepsin H Including the Mini-ChainJournal of Molecular Modeling, 1999
- Specific binding of hoechst 33258 to the d(CGCAAATTTGCG)2 duplex: calorimetric and spectroscopic studiesJournal of Molecular Biology, 1997
- 2-[(2-Pyridylmethyl)sulfinyl]-1H-thieno[3,4-d]imidazoles. A novel class of gastric H+/K+-ATPase inhibitorsJournal of Medicinal Chemistry, 1992
- Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycinJournal of Medicinal Chemistry, 1986